Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes

NCT06913881 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06913881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06913881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Cardiovascular Effectiveness of GLP-1 RAs vs. Insulin in Early-Onset Type 2 Diabetes
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
January 31, 2025
Enrollment
92,100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus (t2dm)